Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers
| Autor: | Bogdan Catargi, Guillaume Charpentier, Pauline Schaepelynck, Michael Joubert, Bruno Guerci, Pierre Fontaine, Hélène Hanaire, Bruno Detournay, Anne Farret, Pierre Simon, Lucy Chaillous, Eric Bavière, Nathalie Jeandidier, Yves Reznik, Alfred Penfornis, Yacine Kherbachi, Sylvia Franc, P. Serusclat, Pierre-Yves Benhamou, Sophie Borot |
|---|---|
| Přispěvatelé: | Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), Laboratory of Fundamental and Applied Bioenergetics = Laboratoire de bioénergétique fondamentale et appliquée (LBFA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Centre Hospitalier Universitaire [Grenoble] (CHU), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Service de Diabétologie - Maladies Métaboliques - Nutrition, CHU Toulouse [Toulouse]-Hôpital de Rangueil, CHU Toulouse [Toulouse], CHU Bordeaux [Bordeaux], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CHU Strasbourg, Marqueurs pronostiques et facteurs de régulations des pathologies cardiaques et vasculaires - UFC ( EA 3920) (PCVP / CARDIO), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Service de Diabétologie - Endocrinologie [CHRU Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôpital Laennec, Centre hospitalier universitaire de Nantes (CHU Nantes), Service de Diabétologie, Hôpital Sud Francilien Corbeil Essonne, Endocrinology, Diabetology and Nutrition, Clinique Portes du Sud, Venissieux, SANOFI Recherche, CEMKA-EVAL, Algèbre, géométrie, logique (AGL), Institut Camille Jordan [Villeurbanne] (ICJ), École Centrale de Lyon (ECL), Université de Lyon-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)-École Centrale de Lyon (ECL), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS), Centre d'études et de recherches pour l'intensification du traitement du diabète (CERITD) |
| Rok vydání: | 2019 |
| Předmět: |
Blood Glucose
Telemedicine type 1 diabetes Computer science [SDV]Life Sciences [q-bio] Health Personnel Endocrinology Diabetes and Metabolism Biomedical Engineering 030209 endocrinology & metabolism Bioengineering Cloud computing Type 2 diabetes Coaching 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Technology Reports Health care Internal Medicine medicine Humans Hypoglycemic Agents Insulin 030212 general & internal medicine ComputingMilieux_MISCELLANEOUS remote monitoring Type 1 diabetes business.industry Blood Glucose Self-Monitoring [CHIM.MATE]Chemical Sciences/Material chemistry medicine.disease Mobile Applications 3. Good health Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 insulin therapy type 2 diabetes Medical emergency business Logbook |
| Zdroj: | Journal of diabetes science and technology Journal of diabetes science and technology, Diabetes Technology Society, 2019, pp.193229681983405 Journal of diabetes science and technology, Diabetes Technology Society, 2019, pp.193229681983405. ⟨10.1177/1932296819834054⟩ |
| ISSN: | 1932-2968 |
| DOI: | 10.1177/1932296819834054 |
| Popis: | Benefits of telemedicine have been proven in the field of diabetes. Among a number of technical solutions, Diabeo® has been studied in both type 1 and type 2 diabetes with intensive insulin therapy. This digital therapeutic system contains a self-monitoring glucose logbook and offers automated insulin dose recommendations thanks to a fully customizable algorithm. In addition, the cloud-based dedicated software also has features to facilitate remote monitoring, including a platform for diabetes nurses who perform coaching and treatment adjustment. A detailed description of this telemedicine system is provided, as well as results of completed clinical studies. In particular, TeleDiab 1’s positive results on HbA1c in type 1 diabetes are detailed. We conclude with a discussion of the role of this telemedicine system within the landscape of mobile apps for diabetes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|